1:10 Stock Split Announced! Record Date Sept 12 – Should You Buy Before The Price Gets Cheaper?

The Board of Fischer Medical Ventures Limited has set a record date for a 1:10 stock split in an effort to increase the liquidity of the company's equity shares on the stock market and to promote more involvement from small and retail investors by making the shares more affordable. By developing innovative, affordable medical imaging technologies and cutting-edge diagnostics advancements globally, the firm is spearheading a paradigm change in the healthcare industry. Fischer Medical Ventures, the first Indian firm to develop sophisticated magnetic resonance imaging (MRI) equipment in India, has its headquarters in Chennai and a production site in Visakhapatnam's Andhra Pradesh MedTech Zone (AMTZ).

Fischer Medical Ventures Stock Split Record Date

"Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to our earlier intimation regarding approval of sub-division/split of equity shares of the Company by the Board of Directors and subsequent approval of shareholders through Postal Ballot, we wish to inform you that the Company has fixed the 12th September 2025 as the Record Date for the purpose of determining the eligibility of members for sub-division/split of shares," said Fischer Medical Ventures in a stock exchange filing.

Fischer Medical Ventures Stock Split Ratio

"The equity shares of Fischer Medical Ventures Limited are listed and traded on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. In order to enhance the liquidity of the Company's equity shares in the stock market and to encourage wider participation from small and retail investors by making the shares more affordable, the Board of Directors of the Company at its meeting held on 28th July 2025, considered and approved the sub-division (split) of the existing equity shares of the Company. The proposal entails sub-dividing 1 (One) equity share of the face value of Rs. 10/- (Rupees Ten only) each fully paid-up into 10 (Ten) equity shares of the face value of Re. 1/- (Rupee One only) each fully paid-up, ranking pari passu in all respects, effective from the Record Date," Fischer Medical Ventures confirmed in a regulatory statement.

"The proposed sub-division will not result in any change to the overall amount of authorized, issued, subscribed, or paid-up share capital of the Company, but will only alter the number of equity shares and their respective face values," Fischer Medical Ventures informed stock exchanges.

The authorized share capital, which was 8 crore shares of Rs 10 each prior to the split, was reformed into 80 crore shares of Rs 1 each after the split, totalling the same Rs 800 crore. In a similar vein, the 6.48 crore shares of Rs 10 each that were issued, subscribed for, and paid up, totaling Rs 648.5 crore, have been adjusted to 64.85 crore shares of Rs 1 each that total Rs 648.5 crore after the split. By raising the number of shares in circulation without changing the company's total market value, this stock split action improves liquidity for Fischer Medical Ventures.

Fischer Medical Ventures Target Price

"Fischer Medical Ventures stock price is slightly bullish & overbought on the Daily charts with strong support at 1085. Investors should be booking profits as a Daily close below support of 1013 could lead to a target of 920 in the near term," commented A R Ramachandran, independent research analyst.

Disclaimer

The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.